Guggenheim Maintains Buy on Twist Bioscience
Guggenheim maintained its Buy rating on Twist Bioscience.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ: TWST ) with a Buy and raises the price target from $60 to $107.